“…The meta-analysis published by Feng and colleagues 82 in 2011 included 5 studies reporting local control rates of T1-T2 glottic cancer and found no significant difference between the treatment modalities. Finally, Abdurehim and colleagues 83 included 10 studies in their meta-analysis of oncologic outcomes for T1a glottic cancer and found no difference between TLM and RT with regard to local control, disease-specific survival, or overall survival. Thus, for Tis, T1, and T2 glottic carcinoma, there is currently no evidence showing a difference in local control, diseasespecific survival, or organ preservation for either surgery or RT.…”